Robeco Schweiz’s Teva Pharmaceuticals TEVA Stock Holding History

Robeco Schweiz’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-27,130	Closed	-$1.79M	–	193
2015 Q4	$1.79M	Sell	27,130 -19,689	-42%	-$1.22M	0.15%	132
2015 Q3	$2.58M	Sell	46,819 -56,681	-55%	-$3.68M	0.24%	122
2015 Q2	$6.14M	Sell	103,500 -3,500	-3%	-$216K	0.51%	67
2015 Q1	$6.69M	Sell	107,000 -8,000	-7%	-$465K	0.53%	62
2014 Q4	$6.55M	Buy	115,000 +13,875	+14%	+$773K	0.5%	70
2014 Q3	$5.42M	Sell	101,125 -24,375	-19%	-$1.29M	0.43%	78
2014 Q2	$6.63M	Sell	125,500 -11,917	-9%	-$609K	0.54%	59
2014 Q1	$6.79M	Buy	137,417 +8,067	+6%	+$373K	0.59%	53
2013 Q4	$5.19M	Sell	129,350 -96,150	-43%	-$3.79M	0.46%	63
2013 Q3	$8.57M	Buy	225,500 +40,000	+22%	+$1.56M	0.72%	38
2013 Q2	$7.19M	Buy	+185,500	New	+$7.22M	0.65%	46

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Robeco Schweiz's TEVA Position: Q1 2016 in Review

Robeco Schweiz sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 27,130 shares — an estimated $1.79M sold.

Robeco Schweiz first reported a position in TEVA in Q2 2013 and held it in 11 quarters. The position peaked at $8.57M in Q3 2013. 836 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Robeco Schweiz reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Robeco Schweiz sold 27,130 Teva Pharmaceuticals shares in Q1 2016, an estimated $1.79M.
Robeco Schweiz first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 11 quarters.
Robeco Schweiz's Teva Pharmaceuticals position peaked at $8.57M in Q3 2013.
836 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Robeco Schweiz's 13F filing for Q1 2016, filed 18 May 2016.